Anagliptin is an amino acid amide. Anagliptin is under investigation for the treatment of LDL Cholesterol, Coronary Disease, Diabetes Mellitus, Glycosylated Hemoglobin, and Dipeptidyl-Peptidase 4 Inhibitors. Anagliptin is an orally available, potent, selective inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Compared to vildagliptin, anagliptin caused longer lasting inhibition of DPP-4 activity. It is grouped under the following drug class(es): DPP-4 inhibitors. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include suiny, anagliptinum and sk-0403. Its PubChem CID is 44513473.
Anagliptin
| CAS No | 739366-20-2 |
|---|---|
| Molecular Formula | C19H25N7O2 |
| Molecular Weight | 383.4 g/mol |
| Synonyms | N-[2-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Anagliptin is an amino acid amide. Anagliptin is under investigation for the treatment of LDL Cholesterol, Coronary Disease, Diabetes Mellitus, Glycosylated Hemoglobin, and Dipeptidyl-Peptidase 4 Inhibitors.
The listed CAS number is 739366-20-2.
The listed molecular formula is C19H25N7O2.
The listed molecular weight is 383.4 g/mol.
N-[2-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide.
The source lists suiny, anagliptinum and sk-0403.